Oxford Nanopore at PMWC 26
)
Overview
PMWC, the Precision Medicine World Conference, is the largest and original annual conference dedicated to precision medicine that brings together recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors. Oxford Nanopore are sponsoring and presenting at this event.
We will also host a Panel Discussion on Wednesday, March 4. See additional details below.
Panel Discussion
Beyond the read: long-read sequencing in clinical variant pipelines
Date: Wednesday, March 4
Time: 11:00 am-11:50 am
Location: Track 4: Systems Integration & Variant Interpretation Track
Space is limited so be sure to register in advance.
Please contact events@nanoporetech.com with any questions.
Speakers
)
Dr. Gordon Sanghera, CEO and co-founder, Oxford Nanopore TechnologiesCEO and co-founder of Oxford Nanopore Technologies, pioneering real-time, scalable DNA RNA sequencing. With a PhD in bioelectronic technology, he led the company from spinout to global player, transforming genomics with portable sequencing devices. Sanghera champions accessible, decentralized sequencing for research, healthcare, and public health worldwide.
)
Dr. Hanlee Ji, Stanford UniversityDr. Hanlee P. Ji is leveraging his expertise in oncology, genetics, and engineering to drive advancements in cancer research. His work integrates molecular technology, computational methods, and genome biology to develop targeted therapies for gastrointestinal cancers and study genomic instability. As a senior figure at the Stanford Genome Technology Center, Dr. Ji's research encompasses immunogenomics, kinase interactions for targeted therapy, and innovative data storage using DNA technologies. He is also involved in clinical trials and translational genomics, aiming to bring scientific discoveries from bench to bedside.
)
Dr. Barrett Bready, CEO & Founder, NabsysBarrett Bready, was founder of Nabsys and CEO from 2005 until 2014 and then again starting in October, 2015. He grew Nabsys from a single employee to 50 and raised $50 million in venture financing to support the companys growth. Barrett Bready is an adjunct professor at Brown University where he teaches Biotechnology Management, a course on thebusiness of biotechnology. He serves as a commissioner of the I-195 Redevelopment District Commission, a large land redevelopment project in downtown Providence with a focus on life sciences and other high technology sectors. He has received numerous awards including, in 2011, Rhode Island Innovator of the Year from Providence Business News. Barrett Bready received an M.D. and an Sc.B. in physics from Brown University, both as part of Browns Program in Liberal Medical Education (PLME).
